Bioforce Nanosciences Holdings, Inc.
BFNH· OTC
BFNHBioforce Nanosciences Holdings, Inc.
Quarterly figures for Bioforce Nanosciences Holdings, Inc., with source filings when available.
36 quarters. Sep 30, 2017 to Jun 30, 2026. USD.
Bioforce Nanosciences Holdings, Inc. has filed its 10-Q within 33 to 50 days of period end across its last 8 quarters. The 10-K runs 42 to 105 days.
Bioforce Nanosciences Holdings, Inc. · CIK 1310488 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 10, 2026 | 41 d | 10-Q | — | — | $0.01 | |
| Q1 2026 | Mar 31, 2026 | — | May 19, 2026 | 49 d | 10-Q | — | — | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Apr 15, 2026 | 105 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | — | Nov 19, 2025 | 50 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Apr 8, 2025 | 98 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | — | Nov 8, 2024 | 39 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Apr 1, 2024 | 92 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 3, 2023 | 34 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 31, 2022 | — | Mar 28, 2023 | 87 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 2, 2022 | 33 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021derived | Dec 31, 2021 | — | Feb 11, 2022 | 42 d | 10-K | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Oct 28, 2021 | 28 d | 10-Q | ||||
| FY 2020 | |||||||||
| Q4 2020derived | Dec 31, 2020 | — | Feb 16, 2021 | 47 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Oct 23, 2020 | 23 d | 10-Q | ||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | Mar 4, 2020 | 64 d | 10-K | $1.00 | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 5, 2019 | ||||||
| FY 2018 | |||||||||
| Q4 2018derived | Dec 31, 2018 | — | Mar 29, 2019 | 88 d | 10-K | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | Oct 24, 2018 | 24 d | 10-Q | ||||
| FY 2017 | |||||||||
| Q4 2017derived | Dec 31, 2017 | — | Apr 13, 2018 | 103 d | 10-K | — | — | — | |
| Q3 2017 | Sep 30, 2017 | — | — | — | — | — | — | $0.00 | |
| — |
| — |
| $0.00 |
| Q2 2025 | Jun 30, 2025 | — | Aug 11, 2025 | 42 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 13, 2025 | 43 d | 10-Q | — | — | -$0.03 |
|---|
| — |
| — |
| $0.00 |
| Q2 2024 | Jun 30, 2024 | — | Aug 7, 2024 | 38 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 3, 2024 | 33 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2023 | Jun 30, 2023 | — | Aug 1, 2023 | 32 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 9, 2023 | 39 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| $0.00 |
| Q2 2022 | Jun 30, 2022 | — | Jul 27, 2022 | 27 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 5, 2022 | 35 d | 10-Q | — | — | — |
|---|
| — |
| — |
| $0.00 |
| Q2 2021 | Jun 30, 2021 | — | Jul 29, 2021 | 29 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2021 | Mar 31, 2021 | — | Apr 27, 2021 | 27 d | 10-Q | — | — | $0.00 |
|---|
| — |
| — |
| -$0.01 |
| Q2 2020 | Jun 30, 2020 | — | Jul 22, 2020 | 22 d | 10-Q | — | — | $0.00 |
|---|
| Q1 2020 | Mar 31, 2020 | — | May 4, 2020 | 34 d | 10-Q | — | — | -$10.35 |
|---|
| 36 d |
| 10-Q |
| $5.96K |
| +8.2% |
| $0.00 |
| Q2 2019 | Jun 30, 2019 | — | Jul 22, 2019 | 22 d | 10-Q | $5.96K | +17.8% | $0.00 |
|---|
| Q1 2019 | Mar 31, 2019 | — | Apr 30, 2019 | 30 d | 10-Q | $5.85K | — | $0.00 |
|---|
| $5.51K |
| — |
| $0.00 |
| Q2 2018 | Jun 30, 2018 | — | Jul 24, 2018 | 24 d | 10-Q | $5.06K | — | $0.00 |
|---|
| Q1 2018 | Mar 31, 2018 | — | May 11, 2018 | 41 d | 10-Q | — | — | $0.00 |
|---|
